Loading...
•
Sep 30, 2024
Conmed Q3 2024 Earnings Report
CONMED's third quarter results were announced, revealing a sales increase of 4.0% year-over-year and GAAP diluted net earnings per share of $1.57.
Key Takeaways
CONMED Corporation reported its third quarter 2024 financial results, with sales increasing by 4.0% year-over-year to $316.7 million. The company's GAAP diluted net earnings per share was $1.57, and adjusted diluted net earnings per share was $1.05, a 16.7% increase compared to the third quarter of 2023.
Sales increased 4.0% year-over-year, reaching $316.7 million.
GAAP diluted net earnings per share was $1.57, compared to $0.50 in Q3 2023.
Adjusted diluted net earnings per share increased 16.7% to $1.05.
COO Patrick Beyer will succeed Curt Hartman as President and CEO effective January 1, 2025.
Conmed
Conmed
Conmed Revenue by Segment
Revenue by Segment
Orthopedic Surgery Revenue
CapyFin.comGeneral Surgery Revenue
CapyFin.com Forward Guidance
Full year reported revenue is now expected to be between $1.300 billion and $1.305 billion. The Company now expects full-year adjusted diluted net earnings per share in the range of $4.00 to $4.05.
Revenue & Expenses
Visualization of income flow from segment revenue to net income